NASDAQ:KRTX
Karuna Therapeutics, Inc. Stock News
$329.83
+0 (+0%)
At Close: May 16, 2024
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commerci
BOSTON--(BUSINESS WIRE)---- $KRTX #NEJM--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living wi
Karuna Therapeutics to Participate at 10th Annual SVB Leerink Global Healthcare Conference
06:30am, Tuesday, 02'nd Feb 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics Announces Appointment of Ronald Marcus, M.D., as Senior Vice President of Medical
06:30am, Tuesday, 26'th Jan 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
06:30am, Tuesday, 05'th Jan 2021
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psyc
Karuna Therapeutics Appoints Denice Torres, J.D., to its Board of Directors
06:34am, Tuesday, 22'nd Dec 2020
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transf
Karuna Therapeutics Appoints David Wheadon, M.D., to Its Board of Directors
09:17am, Thursday, 03'rd Dec 2020
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transf
Karuna Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
06:30am, Tuesday, 10'th Nov 2020
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transf
Karuna Therapeutics (KRTX) Investor Presentation - Slideshow
10:54am, Friday, 11'th Sep 20205 Value Stocks To Watch In The Healthcare Sector
03:46pm, Monday, 17'th Aug 2020
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicator
Karuna Therapeutics (KRTX) Investor Presentation - Slideshow
02:02pm, Thursday, 13'th Aug 2020
The following slide deck was published by Karuna Therapeutics, Inc. in conjunction with this event..
Karuna Therapeutics Appoints Laurie Olson to Board of Directors
10:30am, Thursday, 13'th Aug 2020
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabl
Oppenheimer Reaffirms Their Buy Rating on Karuna Therapeutics (KRTX) - Markets
10:50pm, Wednesday, 05'th Aug 2020
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Karuna Therapeutics (KRTX – Research Report),
Karuna Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
10:00am, Wednesday, 05'th Aug 2020
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabl
Karuna Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
12:00am, Wednesday, 05'th Aug 2020
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the pote
